Product Information
CARTIA XT 180 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.1808 per EA under NDC 62037059805. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
180 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037059805
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074752On Market Since
7/9/1998
Pharmacological Classes
Price Statistics
The NADAC for CARTIA XT 180 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1808 per EA |
|---|---|
| All-time high | $0.4373 (May 13, 2015) |
| All-time low | $0.1492 (Jul 17, 2024) |
| 52-week high | $0.1911 |
| 52-week low | $0.1790 |
| Median price | $0.2708 |
| Average price | $0.2700 |
| Largest weekly change | +44.1% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARTIA XT 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARTIA XT 180 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.1808 per EA (NDC 62037059805), effective Jun 24, 2026.
How has the price of CARTIA XT 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARTIA XT 180 MG CAPSULE has declined 50.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARTIA XT 180 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CARTIA XT 180 MG CAPSULE has ranged from a low of $0.1492 (Jul 17, 2024) to a high of $0.4373 (May 13, 2015), with a median of $0.2708 per EA.
Are there cheaper alternatives to CARTIA XT 180 MG CAPSULE?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 180 MG CAP, is $0.1160 per EA — about 36% below CARTIA XT 180 MG CAPSULE.
Who manufactures CARTIA XT 180 MG CAPSULE?
CARTIA XT 180 MG CAPSULE (NDC 62037059805) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification